Filtered By:
Countries: Japan Health

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 56441 results found since Jan 2013.

Is gene therapy for limb ischemia a reality?
Resumo O conceito de terapia angiog ênica surgiu no início da década de 90, o que pode ser feito com genes que codificam fatores de crescimento para promover a formação de novos vasos e o remodelamento de vasos colaterais. Como o procedimento dessa terapia geralmente consiste em apenas injeções locais de vetores, esse processo é pouco invasivo, rápido e de simples realização. Entretanto, desde as primeiras evidências clínicas do efeito de terapia gênica com o fator de crescimento de endotélio vascular (vascular endothelial growth factor, VEGF) vistos nos pacientes com doença arterial obstrutiva periférica ...
Source: Jornal Vascular Brasileiro - May 29, 2020 Category: Surgery Source Type: research

Association between post-dialysis hemoglobin level and the survival of vascular access.
CONCLUSIONS: A higher post-dialysis hemoglobin level was associated with vascular access failure. Higher post-dialysis Hb could be a factor that triggers vascular access failure. PMID: 29076517 [PubMed - as supplied by publisher]
Source: The Journal of Vascular Access - October 29, 2017 Category: Surgery Tags: J Vasc Access Source Type: research

Current state of dialysis treatment and vascular access management in Japan.
Authors: Sato T, Sakurai H, Okubo K, Kusuta R, Onogi T, Tsuboi M Abstract According to the data from the Japanese Society for Dialysis Therapy, the number of dialysis patients was about 330,000 at the end of 2016. The mean age of newly initiated patients was 69.4 years and that of maintenance was 68.2 years. And, diabetic nephropathy is the most common primary disease, with an incidence rate of 43.2%. These results mean that the systemic vascular condition is getting worse. In spite of these backgrounds, the patients of 97.3% were treated by hemodialysis; therefore, careful management of vascular access is esse...
Source: The Journal of Vascular Access - March 29, 2019 Category: Surgery Tags: J Vasc Access Source Type: research

Current status of vascular access in Japan-from Dialysis Access Symposium 2017.
Authors: Fukasawa M Abstract At the second Dialysis Access Symposium held in Nagoya, Japan, a proposal was made to investigate the differences in vascular access methods used in different countries. In this article, we describe the management of vascular access in Japan. The Japanese population is rapidly aging, and the proportion of elderly patients on dialysis is also increasing. There were 325,000 dialysis patients in Japan at the end of 2015, of whom 65.1% were aged 65 years or above. The number of patients with diabetic nephropathy or nephrosclerosis as the underlying condition is also increasing, whereas th...
Source: The Journal of Vascular Access - May 1, 2019 Category: Surgery Tags: J Vasc Access Source Type: research

Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled Trials
Conclusions The relative treatment effects of BVS and everolimus-eluting stent for the 2-year rates of target lesion failure and other cardiovascular outcomes were consistent in females and males.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - September 18, 2017 Category: Cardiology Authors: Shreenivas, S., Kereiakes, D. J., Ellis, S. G., Gao, R., Kimura, T., Onuma, Y., Piard-Ruster, K., Zhang, Y., Koo, K., Vu, M.-T., Serruys, P. W., Stone, G. W. Tags: Focus on Bioresorbable Vascular Scaffolds Source Type: research

Laminate Medical brings in $12m for dialysis vascular support device
Israeli medtech start-up Laminate Medical Technologies said today that it raised $12 million in a new round of financing slated to support its VasQ vascular support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by constraining and shaping optimal geometrical parameters of the fistula, the company said, and reinforces and shields the vulnerable perianastomotic vein against high pressure, wall tension and flow levels. The round was joined by Asahi Kasei (TYO:3407) and Tal Capital, as well as...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Featured Vascular Laminate Medical Technologies Source Type: news

Current Status of a Nationwide Registry for Vascular Surgery in Japan
In Japan, in 2010, the Surgical Clinical Society established the General Incorporated Association National Clinical Database (NCD) as a surgical case database. This year, 2021, marks the eleventh year since its establishment. The Japanese Society of Vascular Surgery (JSVS) is promoting research in vascular surgery by using these NCD data to compile new evidence to be widely shared to benefit the association ’s members.
Source: European Journal of Vascular and Endovascular Surgery - May 9, 2021 Category: Surgery Authors: Kimihiro Komori Tags: Editorial: Global Tour d'Horizon Source Type: research

Peripheral artery disease is associated with frailty in chronic hemodialysis patients.
Conclusions It is concluded that peripheral artery disease is closely associated with frailty in hemodialysis patients. PMID: 29402196 [PubMed - as supplied by publisher]
Source: Vascular - January 1, 2018 Category: Surgery Authors: Okuyama M, Takeuchi H, Uchida HA, Kakio Y, Okuyama Y, Umebayashi R, Wada K, Sugiyama H, Sugimoto K, Rakugi H, Kasahara S, Wada J Tags: Vascular Source Type: research

Japanese guidelines for the vascular access management for clinical engineers 2016.
Authors: Shibata M PMID: 31032731 [PubMed - in process]
Source: The Journal of Vascular Access - May 1, 2019 Category: Surgery Tags: J Vasc Access Source Type: research

Anti-vascular endothelial growth factor for neovascular glaucoma
CONCLUSIONS: Anti-VEGFs as an adjunct to conventional treatment could help reduce IOP in NVG in the short term (four to six weeks), but there is no evidence that this is likely in the longer term. Currently available evidence regarding the short- and long-term effectiveness and safety of anti-VEGFs in achieving control of IOP, visual acuity, and complete regression of new iris vessels in NVG is insufficient. More research is needed to investigate the effect of these medications compared with, or in addition to, conventional surgical or medical treatment in achieving these outcomes in NVG.PMID:37010901 | PMC:PMC10069372 | D...
Source: Cochrane Database of Systematic Reviews - April 3, 2023 Category: General Medicine Authors: Thanitsara Rittiphairoj Gloria Roberti Manuele Michelessi Source Type: research

Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
CONCLUSIONS: The perioperative use of anti-VEGF reduces the risk of late POVCH, probably results in lower early POVCH risk and may improve visual outcomes. It also reduces the incidence of intraoperative retinal breaks. The evidence is very uncertain about its effect on the need for silicone oil tamponade. The reported complications from its use appear to be low. Agreement on variables included and outcome standardisation is required in trials studying vitrectomy for PDR.PMID:37260074 | PMC:PMC10230853 | DOI:10.1002/14651858.CD008214.pub4
Source: Cochrane Database of Systematic Reviews - June 1, 2023 Category: General Medicine Authors: Panagiotis Dervenis Nikolaos Dervenis Jonathan M Smith David Hw Steel Source Type: research

Anti-vascular endothelial growth factor for neovascular glaucoma.
CONCLUSIONS: Currently available evidence is uncertain regarding the long-term effectiveness of anti-VEGF medications, such as intravitreal ranibizumab or bevacizumab or aflibercept, as an adjunct to conventional treatment in lowering IOP in NVG. More research is needed to investigate the long-term effect of these medications compared with, or in addition to, conventional surgical or medical treatment in lowering IOP in NVG. PMID: 32027392 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - February 5, 2020 Category: General Medicine Authors: Simha A, Aziz K, Braganza A, Abraham L, Samuel P, Lindsley KB Tags: Cochrane Database Syst Rev Source Type: research

Hikikomori: review on a severe phenomenon of social withdrawal
Conclusion Hikikomori is an underdiagnosed and undertreated condition outside Japan, due to the lack of knowledge of health professionals, and for the sufferers ’ refusal to seek help. The phenomenon was not yet included as a psychiatric disorder in the classifications, what difficults the standardization and conduction of research around the world.
Source: Jornal Brasileiro de Psiquiatria - December 17, 2018 Category: Psychiatry Source Type: research

Precision Vascular Anatomy for Minimally Invasive Distal Pancreatectomy: A Systematic Review
ConclusionsThe precise knowledge of peripancreatic vessels is important to adequately complete MIDP. More detailed anatomic analyses and descriptions will benefit surgeons and their patients who are facing these operations.
Source: Journal of Hepato-Biliary-Pancreatic Surgery - February 2, 2021 Category: Surgery Authors: Hitoe Nishino, Giuseppe Zimmitti, Takao Ohtsuka, Mohammed Abu Hilal, Brian K.P. Goh, David A. Kooby, Yoshiharu Nakamura, Shailesh V. Shrikhande, Yoo ‐Seok Yoon, Daisuke Ban, Yuichi Nagakawa, Kohei Nakata, Itaru Endo, Akihiko Tsuchida, Masa Tags: SYSTEMATIC REVIEW Source Type: research